2016 December | The Journal of Targeted Therapies in Cancer

Safety and Efficacy of Combination Targeted Therapy and Radiotherapy

March 09, 2017

Clinical Articles

A review of currently published clinical trials examining the combinaiton of radiation therapy with commonly used targeted agents, such as vascular endothelial growth factor inhibitors, endothelial growth factor receptor inhibitors, and inhibitors of the PI3K/Akt/mTOR pathway.

Neoadjuvant Nivolumab/Ipilimumab Shows Early Promise for Stage III Melanoma

January 23, 2017

Clinical Articles

Neoadjuvant therapy with the combination of nivolumab and ipilimumab is plausible and effective, but can induce a high level of adverse events calling for further research into better tolerated dosing schemes.